NATCOPHARM
NIFTY500
NATCO Pharma Ltd.
Pharma · NSE
₹1,174.70
1Y+42.4%
52-week range
₹771 – ₹1,218
From 52w high
-3.6%
RSI (14)
73.2
vs SMA 50 / 200
↑ 50 · ↑ 200
PE
13.9
Forward PE
30.6
ROE
—
Profit margin
34.1%
D/E
3.01
Dividend yield
0.55%
Quality score
60/100
Revenue growth
36.3%
Earnings growth
13.9%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.